How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

40,582 results for

dementia

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT Full Text available with Trip Pro

Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT Dementia Care Mapping to reduce agitation in care home residents with dementia: the EPIC cluster RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need (...) . >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} There was no benefit of this whole-home, practice development intervention to reduce agitation in care home residents with dementia at 16 months. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , , , , & . Claire A Surr 1, * , Ivana Holloway 2 , Rebecca EA Walwyn 2 , Alys W Griffiths 1 , David Meads 3 , Rachael Kelley 1 , Adam Martin 3 , Vicki McLellan 2 , Clive Ballard 4 , Jane Fossey 5, 6

2020 NIHR HTA programme

2. Dementia: assessment, management and support for people living with dementia and their carers

Dementia: assessment, management and support for people living with dementia and their carers Dementia: assessment, management and Dementia: assessment, management and support for people living with dementia support for people living with dementia and their carers and their carers NICE guideline Published: 20 June 2018 nice.org.uk/guidance/ng97 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility (...) , to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Dementia: assessment, management and support for people living with dementia and their carers

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

3. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting. Full Text available with Trip Pro

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting. The diagnosis of Alzheimer's disease dementia and other dementias relies on clinical assessment. There is a high prevalence of cognitive disorders, including undiagnosed dementia in secondary care settings. Short cognitive tests can be helpful in identifying those who require further specialist diagnostic assessment; however, there is a lack of consensus around the optimal tools (...) to use in clinical practice. The Mini-Cog is a short cognitive test comprising three-item recall and a clock-drawing test that is used in secondary care settings.The primary objective was to determine the diagnostic accuracy of the Mini-Cog for detecting Alzheimer's disease dementia and other dementias in a secondary care setting. The secondary objectives were to investigate the heterogeneity of test accuracy in the included studies and potential sources of heterogeneity. These potential sources

2019 Cochrane

4. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Full Text available with Trip Pro

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. Alzheimer's disease and other forms of dementia are becoming increasingly common with the aging of most populations. The majority of individuals with dementia will first present for care and assessment in primary care settings. There is a need for brief dementia screening instruments that can accurately diagnose dementia in primary care settings. The Mini-Cog is a brief, cognitive (...) screening test that is frequently used to evaluate cognition in older adults in various settings.To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer's disease dementia and related dementias in a primary care setting.We searched the Cochrane Dementia and Cognitive Improvement Register of Diagnostic Test Accuracy Studies, MEDLINE, Embase and four other databases, initially to September 2012. Since then, four updates to the search were performed using the same search methods

2018 Cochrane

5. 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Full Text available with Trip Pro

18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). 18F-florbetaben uptake by brain tissue, measured by positron emission tomography (PET), is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly demonstrated by excluding Alzheimer's pathology (...) in an established dementia diagnosis. However, the National Institute on Aging and Alzheimer's Association (NIA-AA) revised the diagnostic criteria for Alzheimer's disease and confidence in the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease may be increased when using some amyloid biomarkers tests like 18F-florbetaben. These tests, added to the MCI core clinical criteria, might increase the diagnostic test accuracy (DTA) of a testing strategy. However, the DTA of 18F-florbetaben

2017 Cochrane

6. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Full Text available with Trip Pro

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). 18F-flutemetamol uptake by brain tissue, measured by positron emission tomography (PET), is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly demonstrated by excluding Alzheimer's pathology (...) in an established dementia diagnosis. However, the National Institute on Aging and Alzheimer's Association (NIA-AA) revised the diagnostic criteria for Alzheimer's disease and the confidence in the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease may be increased when using some amyloid biomarkers tests like 18F-flutemetamol. These tests, added to the MCI core clinical criteria, might increase the diagnostic test accuracy (DTA) of a testing strategy. However, the DTA of 18F-flutemetamol

2017 Cochrane

7. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Full Text available with Trip Pro

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Research suggests that measurable change in cerebrospinal fluid (CSF) biomarkers occurs years in advance of the onset of clinical symptoms (Beckett 2010). In this review, we aimed to assess the ability of CSF tau biomarkers (t-tau and p-tau) and the CSF tau (t-tau or p-tau)/ABeta ratio to enable the detection of Alzheimer's disease pathology (...) in patients with mild cognitive impairment (MCI). These biomarkers have been proposed as important in new criteria for Alzheimer's disease dementia that incorporate biomarker abnormalities.To determine the diagnostic accuracy of 1) CSF t-tau, 2) CSF p-tau, 3) the CSF t-tau/ABeta ratio and 4) the CSF p-tau/ABeta ratio index tests for detecting people with MCI at baseline who would clinically convert to Alzheimer's disease dementia or other forms of dementia at follow-up.The most recent search

2017 Cochrane

8. Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Full Text available with Trip Pro

Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study found a relatively high prevalence of dementia/mild cognitive impairment in prisons and it developed a care pathway and training materials for staff and prisoners. {{author}} {{($index , , , , , , , , , , , , , , , , , , , , , , & . Katrina Forsyth 1 , Leanne Heathcote 1 , Jane Senior 1, * , Baber Malik 1 , Rachel Meacock 1 , Katherine Perryman 1 , Sue Tucker 1 , Rachel

2020 NIHR HTA programme

9. Identifying features associated with higher-quality hospital care and shorter length of admission for people with dementia: a mixed-methods study Full Text available with Trip Pro

Identifying features associated with higher-quality hospital care and shorter length of admission for people with dementia: a mixed-methods study Identifying features associated with higher-quality hospital care and shorter length of admission for people with dementia: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

2020 NIHR HTA programme

10. Undiagnosed dementia in primary care: a record linkage study Full Text available with Trip Pro

Undiagnosed dementia in primary care: a record linkage study Undiagnosed dementia in primary care: a record linkage study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title (...) }} {{metadata.Headline}} Many people with dementia have no recorded diagnosis and people with dementia but without substantial memory impairments are much less likely to be diagnosed. {{author}} {{($index , , , , , , , , , , & . Clare F Aldus 1 , Antony Arthur 1 , Abi Dennington-Price 2 , Paul Millac 3 , Peter Richmond 4 , Tom Dening 5 , Chris Fox 1 , Fiona E Matthews 6, 7, 8 , Louise Robinson 7, 8 , Blossom CM Stephan 5 , Carol Brayne 9 , George M Savva 1, 10, * 1 School of Health Sciences, University of East

2020 NIHR HTA programme

11. A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT Full Text available with Trip Pro

A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

2020 NIHR HTA programme

12. Amyloid PET in dementia of unclear aetiology

Amyloid PET in dementia of unclear aetiology 1 Translation of the executive summary of the assessment of potential Amyloid-PET bei Demenz unklarer Ätiologie (Version 1.0; Status: 29 May 2018). Please note: This translation is provided as a service by IQWiG to English- language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-03 Amyloid PET in dementia of unclear aetiology 1 Extract of assessment (...) of potential E18-03 Version 1.0 Amyloid PET in dementia of unclear aetiology 29 May 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology Commissioning agency: Federal Joint Committee Commission awarded on: 18 April 2018 Internal Commission No.: E18-03 Address of publisher: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Im Mediapark 8 50670

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

13. Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03)

Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03) 1 Translation of the executive summary of the addendum Amyloid-PET bei Demenz unklarer Ätiologie – Addendum zum Auftrag E18-03 (Version 1.0; Status: 19 July 2018). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. E18-05 Amyloid PET in dementia (...) of unclear aetiology Addendum to Commission E18-03 1 Extract of addendum E18-05 Version 1.0 Amyloid PET in dementia of unclear aetiology 19 July 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Amyloid PET in dementia of unclear aetiology – Addendum to Commission E18-03 Commissioning agency: Federal Joint Committee Commission awarded on: 1 June 2018 Internal Commission No.: E18-05 Address

2020 Institute for Quality and Efficiency in Healthcare (IQWiG)

14. Comorbidity and dementia: a mixed-method study on improving health care for people with dementia (CoDem) Full Text available with Trip Pro

Comorbidity and dementia: a mixed-method study on improving health care for people with dementia (CoDem) Comorbidity and dementia: a mixed-method study on improving health care for people with dementia (CoDem) Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need

2016 NIHR HTA programme

15. The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60-89 years with dementia and qualitative exploration of individual, carer and professional perspectives Full Text available with Trip Pro

The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60-89 years with dementia and qualitative exploration of individual, carer and professional perspectives The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross sectional study of 60-89 year old people with dementia and qualitative exploration of individual, carer and professional perspectives Journals Library An error occurred retrieving

2016 NIHR HTA programme

16. Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care Full Text available with Trip Pro

Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care Improving care for people with dementia: development and initial feasibility study for evaluation of life story work in dementia care Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try

2016 NIHR HTA programme

17. Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions

Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better (...) evidence for healthcare. Navigate this website Activities delivered at home by family carers to maintain cognitive function in people with dementia socially isolating during COVID-19: Evidence for Non – technology based activities / interventions May 7, 2020 Mari Lloyd-Williams, Caroline Mogan, Sarah Russell, Karen Harrison-Dening Academic Palliative and Supportive Care Studies Group, University of Liverpool On behalf of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine

2020 Oxford COVID-19 Evidence Service

18. Covid-19: Advice for aged care providers – residents with dementia

Covid-19: Advice for aged care providers – residents with dementia Advice for aged care providers – residents with dementia 27 APRIL 2020 This advice provides information that may help to: i. reduce transmission of COVID-19 from resident to resident in aged residential care ii. maintain care and quality of life for residents with dementia or cognitive impairment. This advice is additional to, and should be read alongside, other guidance provided for health professionals and specifically (...) for aged residential care, which can be found on health.govt.nz/covid-19. Preventing COVID-19 in residents with dementia COVID-19 is highly contagious. We recognise that social distancing for residents with dementia may be difficult to maintain, and may heighten their anxiety and agitation. Increased staffing may be needed. You and your staff are in a good position to manage the care and wellbeing of your residents with dementia. This includes thinking about, preparing and communicating with residents

2020 Covid-19 Ad hoc guidelines

19. An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study Full Text available with Trip Pro

An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need (...) . >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study suggested that the intervention was both feasible and acceptable to people with dementia and their carers but further research is needed to refine it for a full trial. {{author}} {{($index , , , , , , , , , , , , , , & . Louise M Allan 1, * , Alison Wheatley 2 , Amy Smith 3 , Elizabeth Flynn 4 , Tara Homer 2 , Shannon Robalino 2 , Fiona R Beyer 2 , Christopher Fox 5 , Denise Howel 2 , Robert Barber

2019 NIHR HTA programme

20. Specialist nursing support for unpaid carers of people with dementia: a mixed-methods feasibility study Full Text available with Trip Pro

Specialist nursing support for unpaid carers of people with dementia: a mixed-methods feasibility study Specialist nursing support for unpaid carers of people with dementia: a mixed-methods feasibility study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need (...) . >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This multimethod study may include the largest, independent, national survey of carers of people with dementia to date and it prepares the ground for future evaluation in this challenging area. {{author}} {{($index , , , , , & . Kate Gridley 1, * , Fiona Aspinal 1 , Gillian Parker 1 , Helen Weatherly 2 , Rita Faria 2 , Francesco Longo 2 , Bernard van den Berg 2 1 Social Policy Research Unit, University of York

2019 NIHR HTA programme

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>